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592a Wednesday, March 4, 2009Conotoxins are short peptides that are isolated from predatory marine cone
snail venom. They are unique from other peptides in that they have the ability
to differentiate between various types of ion channels and this makes them ideal
diagnostic tools in the characterization of neuronal pathways and in drug devel-
opment. The subject of our study, a- conotoxins, are 13 to 15-amino acid pep-
tides containing 4 cysteine residues. Thus, three possible regioisomers can form
via disulfide bond formation upon synthesis of these compounds. We report
a method to model the conformational folding of a-conotoxins and the factors
that affect the synthesis of specific regioisomers. We use a combination of mo-
lecular dynamics methods to determine the geometric factors (S-S distance, for
instance) and ab initio methods to determine the conformational energy and
molecular orbital information. Experimental work by the Hargittai group has
determined that the nature of the amino acid at the 9 position strongly directs
the formation of a specific regioisomer. Our model agrees with experimental
observations that identify the role of the amino acid proline in directing the
proper folding of a-conotoxins. We have observed that the presence of proline
(1) directs the folding towards the proper (native) sulfur-sulfur pairs, and (2)
allows less flexibility in the folding. The molecular orbital methodology has
also provided insight into the directionality and energetics of the disulfide
bond formation.
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On the basis of Anfinsen’s thermodynamic hypothesis we have developed
a free-energy forcefield PFF02 for all-atom de-novo protein simulation, which
we recently implemented in a massively parallel computational environment.
POEM (Protein Optimization using Energy Methods), which implements
PFF02 along with several simulation protocols, identifies the native conforma-
tion of the protein as the global minimum of the protein free-energy forcefield.
PFF02 was validated by stabilizing the native conformation of all 32 mono-
meric proteins in the Rosetta decoy sets (without cofactors) against the corre-
sponding decoys. In addition we could fold a set of 24 proteins with helical,
sheet and mixed secondary structure from completely unfolded conformations
to near-native conformations to an average 2.87 A˚ resolution using traditional
computational networks.
The simulations we report here were performed on the POEM@HOME
(http://boinc.fzk.de) volunteer computing architecture using a multiple popu-
lation evolutionary strategy, which explores the free-energy surface in
many parallel Monte-Carlo random walks. Various distinct temperature pop-
ulations are evolved to the global free-energy minimum by balancing energy
improvement and population diversity. This massively parallel algorithm
enables the exploration of the free-energy landscape of relatively large
proteins.
Here we report simulations of three proteins that fold from completely extended
conformations to native structural ensembles within experimental resolution.
The largest of the three is the 43-amino acid fructose-repressor DNA-binding
domain 1UXD. Analyzing the trajectory we find concomitant hydrophobic col-
lapse and secondary structure formation. We observe intermediate collapsed
states with native secondary structure content and few native tertiary contacts,
which subsequently arrange into the native structure.
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Colicin Ia is a bactericidal protein that kills E. coli by making a voltage-depen-
dent ion channel in their inner membrane and de-energizing them. To do this,
the colicin or its pore-forming domain must cross the outer bacterial membrane.
Like all colicins, Ia first binds to an outer membrane receptor. The crystal struc-
ture of colicin Ia bound to its outer membrane receptor, the 22-strand plugged
b-barrel protein, Cir, suggests the plug doesn’t move upon Ia binding. There-
fore, another pathway is needed for the colicin to cross the outer membrane.
Group A colicins, like E3, use the periplasmic and inner membrane proteinsTolA,B,Q,R,Pal in translocation; a second outer membrane protein, such as
the porin OmpF or TolC, has been shown to serve as a ‘‘second receptor’’
and be involved in passage of the colicin across the outer membrane.
Unlike the Tol-dependent colicins, no ‘‘second receptor’’ has ever been identi-
fied for the group B, or TonB-dependent colicins, such as colicin Ia. We show
here that colicin Ia uses one copy of Cir as its receptor, for the initial binding
step, and then searches for a second copy of Cir for translocation across the
outer membrane. We constructed a chimeric colicin with the C-terminal chan-
nel-forming domain and N-terminal translocation domain (T-domain) of coli-
cin Ia and the receptor-binding domain of colicin E3. Although this colicin
now requires the E3 receptor protein, BtuB, presumably for binding, it still re-
quires both the Cir and TonB proteins for killing. Furthermore, we show that
the purified 225-residue colicin Ia T-domain can compete with this hybrid co-
licin and protect E. coli from killing, in vivo. These results imply that the T-do-
main binds to and opens a channel in Cir through which the colicin reaches the
periplasm.
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Intramembrane proteases are a family of highly conserved membrane proteins
that cleave other transmembrane (TM) helical segments within the plane of the
lipid membrane. GlpG rhomboid protease, the best characterized of these intra-
membrane proteases, has six helical segments and a unique loop lying in the
plane of the membrane. TM5 acts as the lateral gate that opens to allow docking
of the incoming substrate; the role of the L1 loop, which extends away from the
active site, is uncertain. Site-directed mutagenesis experiments have identified
a triple serine L1 mutant (Y138S/F139S/L143S) with a significantly reduced
catalytic activity, and a triple valine mutant of the TM5 gate (L229V/F232V/
W236V) with enhanced activity relative to the wild-type protease (Baker et
al, Proc. Natl. Acad. Sci. USA 104, 8257-8262, 2007). To dissect the roles
of TM5 and L1, we performed all-atom molecular dynamics simulations of
the L1 and TM5 mutants in hydrated bilayers of 1-palmytoyl-2-oleoyl-sn-glyc-
ero-3-phosphatidylethanolamine (POPE). The results reveal a relay mechanism
that transmits structural and dynamical perturbations between the remote TM5/
L1 structural elements of the protease. Perturbation of L1 is transmitted to the
active site and TM5 via intra-protein hydrogen bonds to which conserved
amino acid residues contribute. Likewise, perturbation of TM5 leads to changes
in protein dynamics and local structural rearrangements of the remote L1 loop.
In the (inactive) L1 triple serine mutant, but not in the (highly active) TM5 tri-
ple valine mutant, several intra-protein interactions become locked in a new ge-
ometry. The communication between L1 and the TM5 helical gate TM5 sug-
gests a regulatory role for loop L1.
This work was supported by research grants from the National Institute for
General Medical Sciences and the NIH National Center for Research Re-
sources.
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Several new crystal structures published in the past year give insight into the
activation mechanism of G-protein-coupled receptors (GPCRs). The inactive
receptor is stabilized by interactions of TM-3 with TM-7 in the ligand binding
pocket on the extracellular side and with TM-6 on the cytoplasmic side. Both
interactions are weakened upon activation. The helix movement model of re-
ceptor activation suggests that conformational changes in the ligand-binding
pocket are transmitted to the cytoplasmic surface. The model is consistent
with structural changes from the inverse agonist-bound receptor ground state
(rhodopsin) to the G-protein-interacting conformation (‘activated’ opsin). We
demonstrate analogous changes in the TM-3/TM-7 interaction from long mo-
lecular dynamics simulations (>600 ns) of b2-adrenergic receptor (AR) in
two forms, bound to carazolol (inverse agonist) and to adrenaline/epinephrine
(agonist), respectively.[1] The activated opsin structure exhibits movement (tilt
and rotation) of TM-6, which generates the G-protein-binding site and disrupts
stabilizing (‘‘ionic lock’’) interactions of E247(6:30) with the (D/E)RY motif
on TM-3. Movement of TM-6 is independent of a broken ionic lock as seen
in inverse agonist-bound b1/2-AR. On the other hand, movement of TM-6 ap-
pears to be the structural basis for several lipid effects on receptor activation.
We have shown that in bilayer membranes receptor activation is facilitated
by non-lamellar phase-promoting (phospho-) lipids with small head-groups
and/or bulky acyl chains. Moreover, mismatch of bilayer hydrophobic thick-
ness with the receptor results in oligomerization and/or local molecular
Wednesday, March 4, 2009 593acrowding, which in turn inhibits receptor activation. [1] T. Huber, S. Menon,
and T.P. Sakmar. 2008. Current Topics. Structural Basis for Ligand Binding
and Specificity in Adrenergic Receptors: Implications for GPCR-targeted
Drug Discovery. Biochemistry 47, in press.
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Activation of human pancreatic phospholipase A2 (PLA2) in the presence of
DPPC/DPPG (7:3) vesicles was induced by a temperature shift from 4 to 38
oC. PLA2 activity was monitored by changes in fluorescence of bis-Pyrene-
PC (2.5 mol % in the membranes), while simultaneous far- and near-UV cir-
cular dichroism (CD) spectra identified changes in the secondary and tertiary
structures of the protein in real time. The 4-to-38 oC temperature shift caused
dramatic changes in both bis-Pyrene-PC fluorescence and the protein CD
spectra. The monomer fluorescence signal of bis-Pyrene-PC rapidly increased
and the excimer signal decreased, demonstrating PLA2 activation. Drastic
weakening in the a-helical CD signal of the protein, i.e., a 20% decrease
in the n-p* transition intensity at 222 nm, was detected upon enzyme activa-
tion. The a-helical signal exhibited a significantly smaller change upon a sim-
ilar temperature shift under non-catalytic conditions (1 mM EGTA), while
little changes were detected in the absence of lipid. Strong changes in the ter-
tiary structure during PLA2 activation were also identified. Initially, at 4
oC,
the near-UV CD spectra showed a weak negative band around 280 nm. Upon
a shift to 38 oC, strong positive CD bands rapidly developed around 250 and
280 nm, implying significant changes in the conformation and/or the micro-
environment of Tyr and Trp side chains of PLA2, possibly accompanied with
a global tertiary structure perturbation associated with deformation of the
abundant disulfide bonds in the protein. These experiments provide new in-
formation on the structure-function relationship of PLA2 by near-simulta-
neous measurements of PLA2 activity and its secondary and tertiary struc-
tures.
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Human P-glycoprotein (ABCB1) is important in pharmacokinetics, tissue dis-
tribution, oral bioavailability and disposition of therapeutic compounds. Over-
expression of P-glycoprotein can lead to adverse clinical effects such as the
failure of cancer chemotherapy by the induction of multidrug resistance.
Thus a detailed understanding of P-glycoprotein’s drug transport cycle is a pre-
requisite to modulating its various activities. Here we present a detailed ki-
netic and mechanistic model of drug transport by P-glycoprotein. This was
achieved by global fitting of time-based progress curves of the transport of
spin-labeled verapamil as a function of ATP concentrations and measurements
of the force-flux relationships observed during drug transport. By measuring
the ATPase activity simultaneously with the transport velocity in proteolipo-
somes containing purified P-glycoprotein we established a limiting stoichiom-
etry of one ATP hydrolyzed per spin-labeled verapamil molecule transported.
Next, using standard chemical kinetic rate laws, we compared different pro-
posed models of drug transport by trying to globally fit available experimental
data numerically to coupled differential equations generated by each compet-
ing model. Our original seed values and constraints were generated from mea-
surements of KM, Vmax, and Ki values for all reacting ligands during the
steady state transport cycle together with knowledge of the overall thermody-
namics of the transport cycle. We achieved a unique global fit of the progress
curves of spin-labeled verapamil transport as a function of ATP concentration.
A single internally consistent set of rate constants was shown to account for
the data. Additionally, these same rate constants also accounted for the exper-
imentally observed force-flux relationships when utilized in our ‘‘reaction
power stroke’’ model. In contrast we were not able to fit the data as uniquely
and as effectively with other competing drug transport models. Supported by
NIH grant GM52502.
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G-protein coupled receptors (GPCRs) are a large family of integral mem-
brane proteins involved in signal transduction pathways, making them ap-pealing drug targets for a wide spectrum of diseases. The recently solved
X-ray structures of beta1 (B1AR) and beta2 (B2AR) adrenergic receptors
bound to inverse agonists/antagonists open up a large field of potential inves-
tigations to understand the binding modes and mechanisms of activation of
GPCRs.
To investigate their structural and dynamic properties under pseudo in vivo
conditions, we performed extensive molecular dynamics simulations (in an ex-
plicit membrane) of adrenergic receptors in complex with partial inverse ago-
nists and agonists as well as in their apoform. To this end, we applied
MD-based enhanced sampling techniques (steered MD, metadynamics, .) to
describe ligand binding and to elucidate the process of ligand entrance and re-
lease.
In this contribution, we rationalize the differences in binding mode between
B1AR and B2AR for both agonists and antagonists (focusing on a limited set
of key residues surrounding the binding pocket that are different between
B1AR and B2AR). We also discuss main structural changes upon agonist/an-
tagonist binding also in comparison with the most thoroughly studied GPCR,
rhodopsin.
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Metabotropic glutamate receptors (mGluRs) are G protein coupled receptors
which are implicated in different brain functions and dysfunctions including
learning, memory, pain perception, neurodegeneration, schizophrenia and ad-
diction. Metabotropic glutamate receptor type 6 (mGluR6) is a subtype of
mGluRs which is exclusively expressed in ON-bipolar cells and is involved
in night vision. Recent genome-wide association studies have discovered in-
volvement of mGluR6 in heroin addiction. mGluR6 is emerging as a new
drug target but structure-function relationships of this receptor and in general
of mGluRs are poorly understood. These receptors have very low expression
levels in their native cells and are only active in a membrane environment.
The major problem in studying these receptors with biophysical approaches
is in obtaining sufficient quantities of functional protein. To overcome this,
we have constructed a tetracycline inducible mammalian stable cell line ex-
pressing full length human mGluR6. We optimized the detergent and buffer
conditions required for mGluR6 purification. We are developing a reliable,
quantitative in vitro assay for verifying the function of purified mGluR6
in different detergents. We have been successful in developing a medium
scale expression and purification system of mGluR6. Preliminary data sug-
gests that this receptor responds to a number of ligands relevant to its impli-
cated role in vision and addiction with changes in activity and structure as
evidenced by G protein binding and cysteine accessibility measurements, re-
spectively.
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BACE is a novel type I transmembrane aspartyl protease that has been im-
plicated in the pathogenesis of Alzheimer’s disease. Cleavage of the amy-
loid precursor protein by the beta-secretase, BACE, is the first step in the
production of the amyloid-beta peptide and is a prime target for therapeutic
intervention. Using circular dichroism, we provide evidence that show dif-
ferences in stability between active (pH 4.8) and inactive (pH 7.2) BACE.
Active BACE (Tm ~51
C) is comparably much less stable than the inactive
form (Tm ~84
C). In this study we have also examined Ca2þ binding to
BACE, the effect of this binding on the secondary and tertiary structural
characteristics of BACE, and the influence of this binding on the specific
activity of the purified protein. Initially, we used isothermal titration calo-
rimetry to characterize the Ca2þ-BACE interaction. Our results suggest that
there is a high affinity of binding (K¼ 2.0  105 M1) between Ca2þ and
BACE and that the binding process was exothermic (-3.5 kcal/mol). Circu-
lar dichroism and endogenous tryptophan fluorescence measurements dem-
onstrated that the secondary and tertiary structure, respectively, is sensitive
to increasing concentrations of Ca2þ. We also could demonstrate that
low concentrations of Ca2þ (mM) significantly increased the proteolytic ac-
tivity of BACE. Collectively, these results define a role for Ca2þ in both
modulating the structure and proteolytic activity of BACE and suggest
